Morpheus Ventures

Talu Ventures is an early stage technology investor in Australia, with a particular focus on biotechnology, medical devices and pharmaceuticals. Talu was founded in 2012 by three of the partners of CM Capital. Talu's founders have dedicated their careers to the IT and biotech industries and they understand the challenges of building companies from the ground up. In collaboration with Talu's Industry Advisors, portfolio companies can draw upon more than a century of leadership roles within a broad spectrum of successful companies. Talu has been the lead investor in more than 90 percent of its investments.

Tulla Group is the Australian-owned investment group of the Maloney family. Based in Sydney, it was established in the early 1990s with an open mandate focusing on small to middle market listed companies, private equity, venture capital and debt.

BMH Capital is a corporate advisory and ESG investment firm based in Sydney, Australia. Engaging with Innovative | Disruptive | Cutting-edge | Category defining businesses.

Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.

Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.

GV (formerly Google Ventures) is the venture capital arm of Google (Alphabet, Inc.). GV has been investing in technology and biotechnology related companies in the life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture sectors. We have a world-class team of engineers, designers, physicians, scientists, marketers, and investors who work together to provide these startups exceptional support on the road to success. We help our companies interface with Google, providing unique access to the world's best technology and talent. That said, we operate as an independent venture firm that is focused on investment returns. Today, GV has approximately $2.4bn in assets under management and looks to invest $500m per year in start ups. GV is separate to Capital G (formerly Google Capital), which invests in fewer, more mature ventures, with larger deal sizes.